ECSP13012471A - Método de producción de un compuesto intermediario para sintetizar un medicamento - Google Patents
Método de producción de un compuesto intermediario para sintetizar un medicamentoInfo
- Publication number
- ECSP13012471A ECSP13012471A ECSP13012471A ECSP13012471A EC SP13012471 A ECSP13012471 A EC SP13012471A EC SP13012471 A ECSP13012471 A EC SP13012471A EC SP13012471 A ECSP13012471 A EC SP13012471A
- Authority
- EC
- Ecuador
- Prior art keywords
- syntheize
- production
- medicinal product
- intermediary compound
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940126601 medicinal product Drugs 0.000 title 1
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 abstract 1
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Abstract
La presente invención se refiere a un nuevo método para preparar un compuesto de fórmula (2), como intermediario, que puede ser utilizado en forma efectiva para la preparación de un compuesto de fórmula (1), que presenta una buena actividad inhibitoria contra la enzima dipeptidil peptidasa IV.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20100086619 | 2010-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP13012471A true ECSP13012471A (es) | 2013-04-30 |
Family
ID=45023417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP13012471 ECSP13012471A (es) | 2010-09-03 | 2013-03-01 | Método de producción de un compuesto intermediario para sintetizar un medicamento |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8741927B2 (es) |
| EP (1) | EP2611776B1 (es) |
| JP (1) | JP5705985B2 (es) |
| KR (1) | KR101378984B1 (es) |
| CN (1) | CN103080088B (es) |
| AP (1) | AP3270A (es) |
| AR (1) | AR082881A1 (es) |
| AU (1) | AU2011296767B2 (es) |
| BR (1) | BR112013004988B1 (es) |
| CA (1) | CA2810393C (es) |
| CL (1) | CL2013000589A1 (es) |
| CO (1) | CO6700826A2 (es) |
| DK (1) | DK2611776T3 (es) |
| EA (1) | EA022500B1 (es) |
| EC (1) | ECSP13012471A (es) |
| ES (1) | ES2607089T3 (es) |
| HU (1) | HUE032484T2 (es) |
| IL (1) | IL224954B (es) |
| MA (1) | MA34490B1 (es) |
| MX (1) | MX2013002277A (es) |
| MY (1) | MY157423A (es) |
| NZ (1) | NZ607694A (es) |
| PE (1) | PE20131128A1 (es) |
| PH (1) | PH12013500343A1 (es) |
| PL (1) | PL2611776T3 (es) |
| PT (1) | PT2611776T (es) |
| SG (1) | SG188329A1 (es) |
| SI (1) | SI2611776T1 (es) |
| TW (1) | TWI438188B (es) |
| UA (1) | UA107721C2 (es) |
| UY (1) | UY33589A (es) |
| WO (1) | WO2012030106A2 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2995612A1 (en) * | 2014-09-12 | 2016-03-16 | Université de Strasbourg | Novel non-natural amino acids, their process of preparation and uses thereof |
| KR102068754B1 (ko) * | 2017-04-20 | 2020-01-21 | 주식회사 엘지화학 | 의약품 합성용 중간체 화합물의 제조 방법 |
| MX2020003543A (es) * | 2017-09-28 | 2020-07-29 | Lg Chemical Ltd | Metodo de produccion de un compuesto intermediario para sintetizar un medicamento. |
| BR112020006063B1 (pt) * | 2017-09-28 | 2024-01-16 | Lg Chem, Ltd | Método para a preparação de um composto intermediário para sintetizar medicamentos antidiabéticos |
| RU2741389C1 (ru) * | 2017-11-16 | 2021-01-25 | ЭлДжи КЕМ, ЛТД. | Способ получения промежуточного соединения для синтеза лекарственного средства |
| WO2019098551A1 (ko) * | 2017-11-16 | 2019-05-23 | 주식회사 엘지화학 | 의약품 합성용 중간체 화합물의 제조 방법 |
| CN113861061A (zh) * | 2021-10-25 | 2021-12-31 | 成都市科隆化学品有限公司 | 一种不含无机铵盐的氨基酸酰胺盐酸盐及其合成方法 |
| CN117682981A (zh) * | 2022-09-02 | 2024-03-12 | 中国科学院大连化学物理研究所 | 一种吉格列汀药物前体的制备方法 |
| KR20250155700A (ko) | 2024-04-24 | 2025-10-31 | 주식회사 다산제약 | 제미글립틴 산부가염 제조방법 및 이를 유효성분으로 포함하는 dpp-4 저해용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456768A (en) * | 1980-10-08 | 1984-06-26 | The University Of Chicago | Chemical synthesis |
| US5556982A (en) * | 1985-01-14 | 1996-09-17 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| DE3705272A1 (de) * | 1987-02-19 | 1988-09-01 | Basf Ag | Verfahren zur reduktion von mono- und dicarbonsaeuren |
| US5417023A (en) * | 1993-12-27 | 1995-05-23 | Mandish; Theodore O. | Building panel apparatus and method |
| DE60102137T2 (de) * | 2000-03-17 | 2004-10-21 | Bristol Myers Squibb Pharma Co | Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren |
| TWI357902B (en) * | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
| MX2009001442A (es) * | 2006-08-09 | 2009-02-18 | Smithkline Beecham Corp | Pirrolidinona anilinas como moduladores del receptor de progesterona. |
| KR20080071476A (ko) * | 2007-01-30 | 2008-08-04 | 주식회사 엘지생명과학 | 신규한 디펩티딜 펩티데이즈 ｉｖ(ｄｐｐ-ｉｖ) 저해제 |
| EP2220086A4 (en) * | 2007-12-21 | 2010-12-22 | Lg Life Sciences Ltd | DIPEPTIDYLPEPTIDASE IV-INHIBITABLE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREFOR AS ACTIVE AGENT |
-
2011
- 2011-08-25 MX MX2013002277A patent/MX2013002277A/es active IP Right Grant
- 2011-08-25 CN CN201180041893.9A patent/CN103080088B/zh active Active
- 2011-08-25 CA CA2810393A patent/CA2810393C/en active Active
- 2011-08-25 AU AU2011296767A patent/AU2011296767B2/en active Active
- 2011-08-25 SI SI201131045A patent/SI2611776T1/sl unknown
- 2011-08-25 WO PCT/KR2011/006260 patent/WO2012030106A2/en not_active Ceased
- 2011-08-25 BR BR112013004988-0A patent/BR112013004988B1/pt active IP Right Grant
- 2011-08-25 JP JP2013527003A patent/JP5705985B2/ja active Active
- 2011-08-25 MA MA35699A patent/MA34490B1/fr unknown
- 2011-08-25 ES ES11822081.3T patent/ES2607089T3/es active Active
- 2011-08-25 NZ NZ607694A patent/NZ607694A/en unknown
- 2011-08-25 PT PT118220813T patent/PT2611776T/pt unknown
- 2011-08-25 UA UAA201302600A patent/UA107721C2/ru unknown
- 2011-08-25 SG SG2013014931A patent/SG188329A1/en unknown
- 2011-08-25 DK DK11822081.3T patent/DK2611776T3/en active
- 2011-08-25 HU HUE11822081A patent/HUE032484T2/en unknown
- 2011-08-25 MY MYPI2013000673A patent/MY157423A/en unknown
- 2011-08-25 PE PE2013000351A patent/PE20131128A1/es active IP Right Grant
- 2011-08-25 PH PH1/2013/500343A patent/PH12013500343A1/en unknown
- 2011-08-25 US US13/820,197 patent/US8741927B2/en active Active
- 2011-08-25 AP AP2013006763A patent/AP3270A/xx active
- 2011-08-25 EA EA201390336A patent/EA022500B1/ru unknown
- 2011-08-25 EP EP11822081.3A patent/EP2611776B1/en active Active
- 2011-08-25 PL PL11822081T patent/PL2611776T3/pl unknown
- 2011-09-02 TW TW100131640A patent/TWI438188B/zh active
- 2011-09-02 UY UY0001033589A patent/UY33589A/es unknown
- 2011-09-02 AR ARP110103214A patent/AR082881A1/es active IP Right Grant
- 2011-09-02 KR KR1020110089110A patent/KR101378984B1/ko active Active
-
2013
- 2013-02-27 IL IL224954A patent/IL224954B/en active IP Right Grant
- 2013-03-01 CL CL2013000589A patent/CL2013000589A1/es unknown
- 2013-03-01 CO CO13042032A patent/CO6700826A2/es unknown
- 2013-03-01 EC ECSP13012471 patent/ECSP13012471A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP13012471A (es) | Método de producción de un compuesto intermediario para sintetizar un medicamento | |
| UA110197C2 (ru) | Соединения, эффективные как ингибиторы для ксантиноксидазы, процесса получения таких соединений и фармацевтической композиции, содержащей терапевтически эффективное количество таких соединений. | |
| PH12013500554A1 (en) | Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation | |
| MY165087A (en) | Neprilysin inhibitors | |
| EA201491028A8 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| MY182428A (en) | Crystalline forms of a prolyl hydroxylase inhibitor | |
| MY183588A (en) | New salvianolic acid compound l, preparation method and use thereof | |
| TN2012000578A1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
| PH12014501967B1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
| MX341565B (es) | 3-amino-piridinas como agonistas de receptor de acido biliar acoplado a proteina g1 (gpbar1). | |
| MX2013007567A (es) | Procedimiento para preparar poliestereteroles. | |
| MY162786A (en) | Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals | |
| MX2012001411A (es) | Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico. | |
| MX2014004688A (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. | |
| MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. | |
| IN2014DN03245A (es) | ||
| MX2014005538A (es) | 1-piridazinil-hidroxiimino-3-fenil-propanos como agonistas de proteina g-receptor acoplado a acido biliar 1 (gpbar1). | |
| TN2013000075A1 (en) | Production method of intermediate compound for synthesizing medicament | |
| WO2011161295A3 (es) | Uso de compuestos anticalcineurina para el tratamiento de patologías que cursan con neovascularización ocular | |
| MX2011011128A (es) | Un producto lacteo bajo en colesterol para uso como un medicamento. | |
| TH145930A (th) | วิธีการผลิตของสารประกอบตัวกลางสำหรับสารบำบัดรักษาสังเคราะห์ | |
| TN2013000128A1 (en) | Process for preparing pan-cdk inhibitors of the formula (1), and intermediates in the preparation | |
| UA42369U (ru) | Соединение 2-( n-параморфолинофенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность | |
| UA42370U (ru) | Соединение 2-( n-ортотрифторметилфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность | |
| UA44364U (ru) | Соединение 2-(n-ортохлорфенилсукцинимидо-3)-меркаптобензойная кислота, которая имеет потенциальную физиологическую активность |